Veeva Systems Inc.: Veeva Announces Partner Approach for Best-in-Class Randomization and Trial Supply Management

November 1, 2017

Vault EDC combined with IRT software will help improve data quality and speed study execution for the most complex clinical trials.

PLEASANTON, Calif.–(BUSINESS WIRE)– Veeva Systems (NYSE: VEEV) today announced it will partner with leading interactive response technology (IRT) vendors to provide advanced randomization and trial supply management capabilities with Veeva Vault EDC. Veeva is bringing together a modern EDC cloud application with best-in-class randomization and trial supply software to help the life sciences industry improve data quality and accelerate execution when managing complex clinical trials. Veeva’s open partnership approach will allow customers to use Vault EDC with the IRT solution that best meets their needs.Veeva will work with an ecosystem of highly specialized solutions like 4G Clinical, Almac Group, Bracket, IDDI, and YPrime to support sophisticated, adaptive trial designs. Customers will be able to assign patient treatments and supply investigator sites, while ensuring that accurate data flows seamlessly with Vault EDC to streamline trial design and execution. Veeva will also offer stratified randomization as a core capability in Vault EDC.

‘Veeva is committed to customer success and making it easier for companies to use Vault EDC with the software of their choice to manage randomization and their global supply chains,’ said Richard Young, vice president of Vault EDC.

‘Combining a modern EDC application with advanced randomization and supply management will help us ensure we have quality data output for our most sophisticated trials,’ said Kelly Ritch, vice president, clinical trial operations, IND 2 Results. ‘The ability for EDC and IRT solutions to work together is critical to implementing complex study designs with greater speed and efficiency.’

Veeva Vault EDC is a flexible, modern cloud application that helps life sciences companies easily design studies, manage amendments, and improve the speed and quality of data collection in clinical trials. Vault EDC is part of the Veeva Vault Clinical Suite, which also includes Vault eSourceVault CTMSVault eTMFVault Study Startup, and Vault SiteExchange, to streamline clinical operations and clinical data management.


Market Response to Veeva’s Approach

At a recent Veeva partner event, leading IRT vendors shared their thoughts on the opportunity to combine their advanced randomization and supply management capabilities with Vault EDC:

‘4G Clinical is excited about Veeva Systems’ partner approach with Veeva Vault EDC and our Prancer RTSM solution,’ said 4G CEO Dave Kelleher. ‘As the need for speed and flexibility for complex trials increases, it is critical to align with other organizations that support our commitment to bring crucial medicines to those who need them faster.’

‘Almac is proud to collaborate with Veeva on this innovative open partnership approach to offer clients greater flexibility and data quality,’ said George Tiger, vice president of global business development, Almac Group. ‘We look forward to working closely with the Veeva team going forward.’

‘Integrating with EDC and other eClinical systems is an essential component of how Bracket designed our clinical IRT platform,’ said Jim Primerano, GM, eClinical, at Bracket. ‘We are excited about the opportunity to work with Veeva to give their customers a comprehensive solution for their clinical trials.’

‘The seamless integration of modern EDC and IRT solutions is key for the successful conduct and quality delivery of complex clinical trials,’ said Damien Tremolet, CEO of IDDI.

‘It’s exciting when two companies with significant complimentary expertise come together to make things easier for the customers we serve,’ said Shawn Blackburn, CEO of YPrime.


Additional Information

For more on Veeva Vault EDC, visit:

Stay updated on the latest Veeva news on LinkedIn:

Follow @veevasystems on Twitter:

Like Veeva on Facebook:


About Veeva Systems

Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 550 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit


Forward-looking Statements

This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, ‘Risk Factors’ and ‘Management’s Discussion and Analysis of Financial Condition and Results of Operations,’ in the company’s filing on Form 10-Q for the period ended July 31, 2017. This is available on the company’s website at under the Investors section and on the SEC’s website at Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.


Back to news